Clinical • Combination therapy • CAR T-Cell Therapy • PD(L)-1 Biomarker • IO biomarker
|
CD19 (CD19 Molecule) • CD8 (cluster of differentiation 8) • CCL19 (C-C Motif Chemokine Ligand 19)
|
PD-L1 expression • CD19 expression
|
Tevimbra (tislelizumab-jsgr) • cyclophosphamide • fludarabine IV • CD19-7×19 CAR-T